Dr. Thomas D Ramage, M.D. Internal Medicine - Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 1600 North Main, Lovington, NM 88260 Phone: 575-396-6611 Fax: 575-396-1454 |
News Archive
Australian scientists report that they may be on the brink of reversing type 2 diabetes after a genetic discovery. The finding centers on how a particular gene responds to high-fat diets by disrupting insulin production in the pancreas and triggering diabetes.
Millennium: The Takeda Oncology Company today announced that Phase II results of a clinical trial examining VELCADE (bortezomib) in patients with previously untreated aggressive lymphoma were published in the Journal of Clinical Oncology.
AliveCor, Inc. announced today at the start of the 4th annual mHealth Summit in Washington, D.C. that the company received FDA 510(k) clearance on its mobile Heart Monitor as well as CE Mark conformity. This clinical-quality, low-cost mobile ECG heart monitor, compatible with the iPhone® 4 and 4S, enables doctors to evaluate patient heart health easily, quickly and remotely.
Aeras and the China National Biotech Group (CNBG) today announced the signing of a memorandum of understanding for the organizations to pursue opportunities to jointly develop tuberculosis (TB) vaccines in China and potentially other parts of the world.
The first European data on lead extraction was released today by the European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC). The information is published in the EHRA White Book 20131, launched at EHRA EUROPACE 2013 in Athens, Greece, during 23-26 June.
› Verified 4 days ago